Page: 23 of 30 19 20 21 22 23 24 25 26 27

Prof. Ian Tannock Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 Blood pressure and efficacy in patients with metastatic renal cell carcinoma receiving axitinib, from ESMO 2008

Dr Bonanni Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 www.ecancer.tv

Prof. Ian Tannock Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 Sunitinib vs. interferon-alfa as first-line treatment for metastatic renal cancer, from ESMO 2008

Dr Alberto Luini Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 Radioguided Localisation (ROLL) of breast lesions. From the Milan Breast Cancer Conference

Dr Garbal Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 From the Milan Breast Cancer Conference.

Professor Alan Coates Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 From the Milan Breast Cancer Conference.

Dr Ari Teresa Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 www.ecancer.tv

Prof. Alan Horwich Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 Incidence of contralateral germ cell tumours, from ESMO 2008

Prof. Alan Horwich Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 Sexual function after treatment for testicular cancer, from ESMO 2008

Dr Marco Merlano Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 Chemotherapy, radiotherapy and cetuximab in head and neck cancer.

Prof. Poulam Patel Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 Extended, escalated dose chemo shows no survival benefit in advanced melanoma.

Dr. Nils Wilking Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 European disparities in access to cancer drugs.

Prof. Tony Mok Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 Gefitinib for asian non-smokers with lung cancer.

John Smyth Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 The new ECCO launches in Barcelona with an interview from John Smyth, ECCO 14 Chair.

Professor Gunter von Minckwitz Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 New chemotherapy combo produces side effects, but no extra efficacy, in early breast cancer patients.

Prof. Bradley Monk Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 Promising new treatment option for women with recurrent ovarian cancer.

Prof Ian Judson Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 The latest new treatment - Trabectedin (Yondelis®) for metastatic or advanced soft tissue sarcoma

Prof. Martine Piccart Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 Calls for greater cancer drug funding from governments and emphasises targeted therapy.

Professor Eric Van Cutsem Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 www.ecancer.tv

Prof. Michael Untch Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 Trastuzumab with chemo before surgery for women with HER2 positive tumours.

Page: 23 of 30 19 20 21 22 23 24 25 26 27